The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

被引:828
作者
Steffan, JS
Kazantsev, A
Spasic-Boskovic, O
Greenwald, M
Zhu, YZ
Gohler, H
Wanker, EE
Bates, GP
Housman, DE
Thompson, LM [1 ]
机构
[1] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA
[2] MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA
[3] Univ London Kings Coll, Guys Hosp, GKT Sch Med, London SE1 9RT, England
[4] Max Planck Inst Mol Genet, D-14195 Berlin, Germany
关键词
D O I
10.1073/pnas.100110097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Huntington's Disease (HD) is caused by an expansion of a polyglutamine tract within the huntingtin (htt) protein. Pathogenesis in HD appears to include the cytoplasmic cleavage of htt and release of an amino-terminal fragment capable of nuclear localization. We have investigated potential consequences to nuclear function of a pathogenic amino-terminal region of htt (httex1p) including aggregation, protein-protein interactions, and transcription. httex1p was found to coaggregate with p53 in inclusions generated in cell culture and to interact with p53 in vitro and in cell culture. Expanded httex1p represses transcription of the p53-regulated promoters, p21(WAF1/CIP1) and MDR-1, httex1p was also found to interact in vitro with CREB-binding protein (CBP) and mSin3a. and CBP to localize to neuronal intranuclear inclusions in a transgenic mouse model of Ho. These results raise the possibility that expanded repeat htt causes aberrant transcriptional regulation through its interaction with cellular transcription factors which may result in neuronal dysfunction and cell death in HD.
引用
收藏
页码:6763 / 6768
页数:6
相关论文
共 53 条
[1]   CREB-binding protein in androgen receptor-mediated signaling [J].
Aarnisalo, P ;
Palvimo, JJ ;
Jänne, OA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2122-2127
[2]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[3]   Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene [J].
Cha, JHJ ;
Kosinski, CM ;
Kerner, JA ;
Alsdorf, SA ;
Mangiarini, L ;
Davies, SW ;
Penney, JB ;
Bates, GP ;
Young, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6480-6485
[4]   MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[5]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[6]  
Davies SW, 1999, METHOD ENZYMOL, V309, P687
[7]   The role of apoptosis in neurodegenerative diseases [J].
Desjardins, P ;
Ledoux, S .
METABOLIC BRAIN DISEASE, 1998, 13 (02) :79-96
[8]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[9]   HUNTINGTIN IS A CYTOPLASMIC PROTEIN ASSOCIATED WITH VESICLES IN HUMAN AND RAT-BRAIN NEURONS [J].
DIFIGLIA, M ;
SAPP, E ;
CHASE, K ;
SCHWARZ, C ;
MELONI, A ;
YOUNG, C ;
MARTIN, E ;
VONSATTEL, JP ;
CARRAWAY, R ;
REEVES, SA ;
BOYCE, FM ;
ARONIN, N .
NEURON, 1995, 14 (05) :1075-1081
[10]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825